FLUIDDA is the world leader in the field of Functional Respiratory Imaging. This technique combines HRCT scans and Computational Fluid Dynamics technology, enabling the assessment of treatment responses, and helping physicians to make... View Article
A well powered study with FRI as primary endpoint shows the potential of an inhaled P13K delta inhibitor in COPD-exacerbations. A recent paper, published in the Int. Journal of Chronic Obstructive... View Article
Dr. Muhunthan Thillai is a pulmonologist at Cambridge University, specialized in pulmonary fibrosis; and co-founder and CEO of Qur8, an imaging platform for analyzing large clinical sets of data. He is... View Article
In the recently published “Fluidda’s Magazine on FRI”, Dr. Langton, pulmonologist at the University of Melbourne specialized in bronchial thermoplasty treatment, was interviewed about his experiences with FRI and his... View Article
Metered dose inhalers (MDI’s) are one of the most common device types for delivering inhaled therapies. However, there are several technical challenges in development and drug delivery of these medications.... View Article
In a recent study by Usmani et al. , FRI was used to evaluate lung deposition of extrafine beclomethasone dipropionate (BDP)/formoterol fumarate (FF)/glycopyrronium bromide (GB) and extrafine BDP/FF delivered through pressurized metered... View Article
FRI is able to differentiate moderate to severe versus limited disease and to detect disease progression in systemic sclerosis. Systemic sclerosis–associated ILD accounts for up to 20% of mortality in these patients... View Article
FRI on PBS news hour: Medical community scrambles to understand COVID-19 ‘long haulers’ During a news item on PBS news hour, January 13, COVID-19 “long haulers” were discussed. Long haulers are COVID-19 patients... View Article
Galapagos Announces Positive Topline Results in Phase 2 Study Using FRI Imaging Parameters While Investigating New Medication for IPF Patients. The PINTA trial was a randomized, double-blind, placebo-controlled trial investigating... View Article
Fluidda’s FRI-activities are at “Full Speed” during this COVID-19 pandemic The COVID-19 crisis has had a tremendous impact on the initiation and progression of clinical research around the world and... View Article